Capricor Therapeutics

1 follower

‌

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Industries

Biotechnology

Headquarters

Beverly Hills, United States

Employees

11-50

Links

Org chart

Linda Marbán

Chief Executive Officer

Linda Marbán

Collapse

Aj Bergmann

Chief Financial Officer

Kristi A. H. Elliott

Chief Science Officer

Mark Awadalla

Chief Development Officer (cdo)

Yushi Feng

VP of Regulatory Affairs

Jonathan Tayco

Vice President Of Program Management, Operations And Quality

Joe Z.

Senior IP Counsel

Teams

+24

Research and Development

27 members

Leadership Team

3 members

Finance and Accounting

3 members

Similar companies

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Day One Biopharmaceuticals

1 follower

QurAlis

1 follower

Edgewise Therapeutics

1 follower

Abcuro

1 follower

Generate Biomedicines

3 followers

Qureator

1 follower

OncoPrecision

11 followers

eGenesis

1 follower

Thermo Fisher Scientific

173 followers

Explore companies